Understanding the Major Workplace Causes of Cancer in Canada Date held: April 25, 2019 Presented by: Dr. Paul Demers, Director of the Occupational Cancer Research Centre and Professor with the University of Toronto Webinar Information: Every year in Canada thousands of people are diagnosed with cancer caused by their work and millions of people continue to be exposed to workplace carcinogens. In this webinar, Dr.
Last week, Prince Edward Island agreed to a new healthcare accord with the federal government, securing an additional $45.1 million over the next ten years. British Columbia, Alberta, Manitoba, Ontario and Quebec still remain without a new agreement. When asked about the new accord, federal Health Minister Jane Philpott stated, “They’ve got some great plans there [Prince Edward Island] about how they want to make
On Friday, February 3rd, CCSN opened their doors in recognition of World Cancer Day! An annual event held at the CCSN office, this years’ edition was a huge success with many people in attendance. “Friday’s Open House was a great demonstration on how so many people can be affected by cancer,“ said Kati Oliver, CCSN Programs and Projects Manager. “This was a fantastic way for
In the last couple of days, three territorial governments as well as one provincial government have signed separate, bilateral healthcare agreements with the federal government. The Northwest Territories, Nunavut, Yukon and Saskatchewan join New Brunswick, Nova Scotia and Newfoundland and Labrador as provinces/territories who have signed separate deals in the past month. The breakdowns for the new agreements are: Northwest Territories will receive $7.4 million
This story was originially posted on CUREToday.com and is being shared with the permission of the author. Certainty takes on a whole new meaning when you are living with cancer When I was diagnosed with a rare leukemia eight years ago, I struggled with anxiety for about a year, despite a good prognosis. In fact, it was better than good. Generally well-managed with medication, chronic myelogenous leukemia
The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of Opdivo (nivolumab) for the treatment of patients with Squamous Cell Carcinoma of the Head and Neck. The results of our survey are to be submitted in our patient evidence study to the pan-Canadian Oncology Drug Review (pCODR) on February 14, 2017.